Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gastrointestinal 1

Conditions

Thymoma 1Sarcoma 1Biliary Tract Neoplasms 1

Interventions

Specimen Handling 176Magnetic Resonance Spectroscopy 138Biopsy 102pembrolizumab 81Carboplatin 79Cisplatin 71Nivolumab 65Cyclophosphamide 64Paclitaxel 54Radiotherapy 48Gemcitabine 43durvalumab 39Doxorubicin 35Bevacizumab 34Fluorouracil 33venetoclax 32Dexamethasone 31Rituximab 30atezolizumab 29Radiation 29Capecitabine 28Lenalidomide 27Etoposide 27Prednisone 26Oxaliplatin 26Injections 26Pemetrexed 25Docetaxel 25olaparib 23fludarabine 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × envafolimab × 30 days × Clear all
NCT07599995 2026-05-20

GENE

Sir Run Run Shaw Hospital

Phase 2 Not yet recruiting
34 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT05941325 2026-05-14

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Shanghai 6th People's Hospital

Phase 2 Suspended
20 enrolled
Sarcoma

Sarcoma

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting
25 enrolled
Thoracic

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡